TG Therapeutics, Inc. (TGTX)
56.05
+1.78
(+3.28%)
USD |
NASDAQ |
Aug 24, 16:00
56.45
+0.40
(+0.71%)
After-Hours: 20:00
TG Therapeutics Debt to Equity Ratio : 1.249 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.249 |
| March 31, 2026 | 1.292 |
| December 31, 2025 | 0.3915 |
| September 30, 2025 | 0.4178 |
| June 30, 2025 | 0.9178 |
| March 31, 2025 | 1.069 |
| December 31, 2024 | 1.141 |
| September 30, 2024 | 1.321 |
| June 30, 2024 | 0.6338 |
| March 31, 2024 | 0.6975 |
| December 31, 2023 | 0.6903 |
| September 30, 2023 | 0.667 |
| June 30, 2023 | 2.695 |
| March 31, 2023 | 3.942 |
| December 31, 2022 | 1.418 |
| September 30, 2022 | 0.8184 |
| June 30, 2022 | 0.6231 |
| March 31, 2022 | 0.464 |
| December 31, 2021 | 0.3333 |
| September 30, 2021 | 0.0882 |
| June 30, 2021 | 0.0909 |
| March 31, 2021 | 0.0943 |
| December 31, 2020 | 0.0826 |
| September 30, 2020 | 0.2435 |
| June 30, 2020 | 0.213 |
| Date | Value |
|---|---|
| March 31, 2020 | -30.40 |
| December 31, 2019 | 1.062 |
| September 30, 2019 | -1.535 |
| June 30, 2019 | 2.878 |
| March 31, 2019 | 1.966 |
| December 31, 2018 | 0.0028 |
| September 30, 2018 | 0.0013 |
| June 30, 2018 | 0.0021 |
| March 31, 2018 | 0.0026 |
| December 31, 2017 | 0.0019 |
| September 30, 2017 | 0.0023 |
| June 30, 2017 | 0.002 |
| March 31, 2017 | 0.0017 |
| December 31, 2016 | 0.0019 |
| September 30, 2016 | 0.0021 |
| June 30, 2016 | 0.0012 |
| March 31, 2016 | 0.0017 |
| December 31, 2015 | 0.0021 |
| September 30, 2015 | 0.0016 |
| June 30, 2015 | 0.0026 |
| March 31, 2015 | 0.0026 |
| December 31, 2014 | 0.0034 |
| September 30, 2014 | 0.0027 |
| June 30, 2014 | 0.0031 |
| March 31, 2014 | 0.0021 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Krystal Biotech, Inc. | 0.0065 |
| MAIA Biotechnology, Inc. | 0.00 |
| Vericel Corp. | 0.2556 |
| Incyte Corp. | 0.006 |
| Regeneron Pharmaceuticals, Inc. | 0.0854 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.640B |
| Total Liabilities (Quarterly) | 1.036B |
| Shareholders Equity (Quarterly) | 604.08M |
| Current Ratio | 4.267 |
| Net Debt Paydown Yield | -1.19% |